A 1-hour sample-to-answer, molecular device successfully detected common causative pathogens of acute febrile illness with high positive and negative percent agreement directly in whole blood, ...
MARCY L’ÉTOILE, France--(BUSINESS WIRE)-- Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, today announced that BioFire Diagnostics, its subsidiary ...
MONTREAL, Feb. 25, 2025 /CNW/ - bioMérieux, a world leader in the field of in vitro diagnostics, has achieved a significant milestone with the Health Canada approval of the BIOFIRE ® SPOTFIRE ® ...
Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks bioMérieux’s BIOFIRE® FILMARRAY® ...
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...
SALT LAKE CITY--(BUSINESS WIRE)--BioFire Diagnostics, Inc. announced today that it obtained the CE IVD Mark under the European Directive on In Vitro Diagnostic Medical Devices for its FilmArray Blood ...
Sloane Street Surgery's BioFire testing provides same-day identification of infections, allowing faster, safer and more targeted treatment London, United Kingdom--(Newsfile Corp. - November 24, 2025) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback